NCT02291471View on ClinicalTrials.gov

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Rheumatic Diseases
Interventions
DRUG

T0001，10mg

DRUG

T0001，20mg

DRUG

T0001，35mg

DRUG

T0001，50mg

DRUG

T0001，65mg

DRUG

T0001，75mg

Trial Locations (1)

100044

Phase I laboratory of Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT02291471 - Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers | Biotech Hunter | Biotech Hunter